All Pharma News
Enveric Biosciences Announces Patent Granted for Drug Candidate

Enveric Biosciences Announces Patent Granted for Drug Candidate
BUSINESSWIRE
10 Jul 2024
Share Share
Enveric elevates EB-003 as lead development candidate with strategic update.

Enveric elevates EB-003 as lead development candidate with strategic update.
BUSINESSWIRE
25 Jun 2024
Share Share
Enveric Biosciences to Participate in BIO International Convention 2024

Enveric Biosciences to Participate in BIO International Convention 2024
BUSINESSWIRE
30 May 2024
Share Share
Enveric Biosciences to out-license psilocin prodrug to MindBio

Enveric Biosciences to out-license psilocin prodrug to MindBio
PHARMACEUTICAL TECHNOLOGY
15 May 2024
Share Share
Enveric Biosciences Reports First Quarter 2024 Financial and Corporate Results

Enveric Biosciences Reports First Quarter 2024 Financial and Corporate Results
BUSINESSWIRE
15 May 2024
Share Share
Enveric Biosciences: Non-Binding Term Sheet for Cancer Treatment

Enveric Biosciences: Non-Binding Term Sheet for Cancer Treatment
BUSINESSWIRE
08 May 2024
Share Share
Enveric Biosciences Reports Financial Results and Provides Corporate Update

Enveric Biosciences Reports Financial Results and Provides Corporate Update
BUSINESSWIRE
26 Mar 2024
Share Share
Enveric Signs Non-Binding Term Sheets to Pursue the Exclusive Out-Licensing

Enveric Signs Non-Binding Term Sheets to Pursue the Exclusive Out-Licensing
BUSINESSWIRE
19 Mar 2024
Share Share
Enveric Biosciences Announces New Patent Issuances Protecting Multiple Assets

Enveric Biosciences Announces New Patent Issuances Protecting Multiple Assets
BUSINESSWIRE
12 Mar 2024
Share Share
Enveric Biosciences Signs Non-Binding Term Sheets

Enveric Biosciences Signs Non-Binding Term Sheets
BUSINESSWIRE
29 Feb 2024
Share Share